HCV-GENOFIBROTEST: A COMBINATION OF VIRAL, LIVER AND GENOMIC (IL28B, ITPA, UGT1A1) BIOMARKERS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C

被引:0
|
作者
Costa, J. M. [1 ]
Telehin, D. [2 ]
Munteanu, M. [3 ]
Kobryn, T.
Ngo, Y. [3 ]
Thibault, V. [4 ]
Moussalli, J. [5 ]
Ratziu, V. [5 ]
Benhamou, Y. [5 ]
Koz'ko, V. [6 ]
Dubins'ka, G. [7 ]
Poveda, J. D. [1 ]
Poynard, T. [5 ]
机构
[1] Pasteur Cerba, Cergy Pontoise, France
[2] Natl Med Univ, Dept Infect Dis, Lvov, Ukraine
[3] Biopredictive, Hepatol, Paris, France
[4] Hop La Pitie Salpetriere, Dept Virol, Paris, France
[5] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Hepatol Dept,Liver Ctr, Paris, France
[6] Natl Med Univ, Kharkov, Ukraine
[7] Ukrainian Med Stomatol Acad, Poltava, Ukraine
关键词
D O I
10.1016/S0168-8278(11)61335-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1333
引用
收藏
页码:S526 / S526
页数:1
相关论文
共 50 条
  • [31] VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Doi, Yoshinori
    Ogawa, Hiroyuki
    Hagiwara, Hideki
    Mita, Eiji
    Kaneko, Akira
    Katayama, Kazuhiro
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijirou
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2011, 54 : 852A - 853A
  • [32] IL28B BUT NOT ITPA POLYMORPHISM IS ASSOCIATED WITH RESPONSE TO PEG-INTERFERON, RIBAVIRIN AND TELAPREVIR TRIPLE THERAPY IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1
    Hayes, C. Nelson
    Abe, Hiromi
    Miki, Daiki
    Ochi, Hidenori
    Karino, Yoshiyasu
    Toyota, Joji
    Sezaki, Hitomi
    Kobayashi, Mariko
    Akuta, Norio
    Suzuki, Fumitaka
    Kumada, Hiromitsu
    Chayama, Kazuaki
    HEPATOLOGY, 2011, 54 : 832A - 832A
  • [33] IL28B POLYMORPHISM PREDICTS VIROLOGIC RESPONSE IN PATIENTS WITH HEPATITIS C GENOTYPE 1 TREATED WITH BOCEPREVIR (BOC) COMBINATION THERAPY
    Poordad, F.
    Bronowicki, J. -P.
    Gordon, S. C.
    Zeuzem, S.
    Jacobson, I. M.
    Sulkowski, M. S.
    Poynard, T.
    Morgan, T. R.
    Burroughs, M.
    Sniukiene, V.
    Boparai, N.
    Brass, C. A.
    Albrecht, J. K.
    Bacon, B. R.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S6 - S6
  • [34] IL28B Polymorphism Predicts Virologic Response in Patients With Hepatitis C Genotype 1 Treated With Boceprevir (Boc) Combination Therapy
    Poordad, Fred
    Bronowicki, Jean-Pierre
    Gordon, Stuart C.
    Zeuzem, Stefan
    Jacobson, Ira M.
    Sulkowski, Mark
    Poynard, Thierry
    Morgan, Timothy R.
    Burroughs, Margaret
    Sniukiene, Vilma
    Boparai, Navdeep
    Brass, Clifford A.
    Albrecht, Janice K.
    Bacon, Bruce R.
    GASTROENTEROLOGY, 2011, 140 (05) : S941 - S941
  • [35] Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C
    Boglione, Lucio
    Cusato, Jessica
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    INFECTION GENETICS AND EVOLUTION, 2017, 53 : 195 - 198
  • [36] IL28B polymorphisms predict Rapid Virologic Response to therapy among chronic hepatitis C patients with HCV genotype 5
    Antaki, Nabil
    Abboud, Dirar
    HEPATOLOGY, 2012, 56 : 1033A - 1033A
  • [37] IL28B polymorphism predicts virologic response in patients with hepatitis C genotype 1 treated with boceprevir (BOC) combination therapy
    Bognar, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 19 - 20
  • [38] Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients
    Dzekova-Vidimliski, Pavlina
    Nikolov, Igor G.
    Matevska-Geshkovska, Nadica
    Mena, Sami
    Rostaing, Lionel
    Dimovski, Aleksandar
    Sikole, Aleksandar
    RENAL FAILURE, 2015, 37 (07) : 1180 - 1184
  • [39] Reply to "Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C"
    Estrabaud, Emilie
    Lada, Olivier
    Asselah, Tarik
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 706 - 707
  • [40] IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population
    Dong, Zhi Xia
    Zhou, Hui Juan
    Xiang, Xiao Gang
    Guo, Si Min
    Zhuang, Yan
    Zhao, Gang De
    Xie, Qing
    JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (02) : 90 - 97